Saturday 17 October 2026
Export RMD’s income statement to Excel — free account
ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
238.97
3.26
−1.35%
Follow RMD
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 6 | 7 | 5 | 5 | 3 | 5 | 8 | 6 |
P/E ratio |
32.18 | 46.75 | 43.73 | 44.55 | 75.39 | 39.33 | 35.76 | 26.94 | 27.02 | 18.63 |
Altman Z-Score |
6.76 | 11.50 | 7.25 | 10.29 | 14.05 | 13.22 | 9.69 | 10.99 | 13.01 | 10.00 |
P/S ratio |
5.33 | 6.33 | 6.79 | 9.37 | 11.21 | 8.56 | 7.59 | 5.87 | 7.36 | 5.02 |
Altman Z″-Score (non-manufacturers) |
6.79 | 7.11 | 4.89 | 5.77 | 5.97 | 7.26 | 6.40 | 7.58 | 8.65 | 9.10 |
P/FCF ratio |
32.13 | 34.17 | 46.40 | 39.80 | 57.79 | 156.94 | 57.34 | 21.37 | 22.93 | 17.41 |
P/Operating CF |
78.45 | 114.48 | 124.89 | 83.91 | 158.14 | 385.22 | 135.06 | 62.45 | 70.26 | 62.38 |
Beneish M-Score |
(2.44) | (2.45) | (2.63) | (2.73) | (2.42) | (2.10) | (2.14) | (2.48) | (2.61) | (2.59) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 96 |
P/B ratio |
5.62 | 7.20 | 8.55 | 11.10 | 12.41 | 9.11 | 7.76 | 5.65 | 6.34 | 4.31 |
Price to Tangible BV |
17.37 | 19.12 | 0.00 | 174.81 | 63.38 | 28.39 | 39.72 | 17.89 | 15.41 | 8.80 |
EV/Sales |
5.45 | 6.37 | 7.22 | 9.61 | 11.31 | 8.69 | 7.88 | 5.96 | 7.25 | 4.83 |
EV/EBITDA |
20.94 | 22.51 | 25.78 | 28.67 | 33.03 | 26.05 | 25.03 | 18.19 | 19.42 | 12.81 |
EV/Operating CF |
27.21 | 29.50 | 41.00 | 35.42 | 49.10 | 88.60 | 47.99 | 19.94 | 21.30 | 15.11 |
EV/FCF |
32.88 | 34.36 | 49.31 | 40.81 | 58.35 | 159.46 | 59.49 | 21.72 | 22.59 | 16.76 |
Quick Ratio |
3.53 | 1.32 | 1.22 | 1.56 | 1.00 | 1.23 | 1.23 | 1.18 | 2.11 | 1.80 |
Current Ratio |
4.57 | 2.08 | 2.06 | 2.53 | 1.73 | 2.80 | 3.12 | 2.59 | 3.44 | 3.10 |
Net Debt/EBITDA |
0.48 | 0.12 | 1.52 | 0.71 | 0.32 | 0.41 | 0.91 | 0.30 | (0.29) | (0.50) |
Debt/Assets |
31.10% | 8.81% | 30.65% | 25.38% | 13.61% | 15.02% | 21.20% | 10.15% | 8.05% | 4.45% |
Debt/Equity |
0.55 | 0.13 | 0.61 | 0.47 | 0.22 | 0.23 | 0.35 | 0.14 | 0.11 | 0.06 |
Asset Turnover |
0.61 | 0.72 | 0.73 | 0.68 | 0.69 | 0.73 | 0.71 | 0.69 | 0.68 | 0.66 |
Operating CF/Net income |
1.21 | 1.60 | 1.13 | 1.29 | 1.55 | 0.45 | 0.77 | 1.37 | 1.25 | 1.19 |
Capex/Depreciation |
(0.64) | (0.60) | (0.51) | (0.58) | (0.61) | (0.80) | (0.68) | (0.53) | (0.43) | (0.73) |
Interest Coverage |
15.08 | 19.11 | 16.02 | 20.57 | 38.25 | 44.83 | 23.89 | 28.88 | (409.67) | (37.80) |
| 18.73% | 15.70% | 19.59% | 27.21% | 17.63% | 24.96% | 23.96% | 22.70% | 25.86% | 24.27% | |
| 10.18% | 9.66% | 11.28% | 14.30% | 10.19% | 15.87% | 15.15% | 14.99% | 18.62% | 17.77% | |
ROIC |
12.00% | 15.82% | 11.37% | 15.82% | 17.47% | 16.23% | 13.26% | 15.50% | 19.45% | 21.38% |
Return on Tangible Assets |
20.40% | 33.54% | 41.42% | 46.46% | 42.12% | 44.79% | 41.80% | 51.17% | 46.12% | 43.38% |
Average Days of Receivables |
79.57 | 75.44 | 74.00 | 58.59 | 70.14 | 58.75 | 60.93 | 65.23 | 66.63 | 66.90 |
Research and Development Expense of Revenue |
6.99% | 6.63% | 6.93% | 6.83% | 7.05% | 7.09% | 6.81% | 6.56% | 6.44% | 6.69% |
Selling, General and Administrative Expense of Revenue |
26.80% | 25.65% | 24.75% | 22.88% | 20.97% | 20.61% | 20.70% | 19.57% | 19.30% | 19.80% |
Intangible Assets out of Total Assets |
0.38 | 0.42 | 0.58 | 0.51 | 0.49 | 0.45 | 0.49 | 0.48 | 0.43 | 0.38 |
Share Based Compensation of Revenue |
2.22% | 2.07% | 2.00% | 1.95% | 2.00% | 1.82% | 1.68% | 1.71% | 1.78% | 1.85% |
Graham Net Nets |
0.01 | 0.00 | (0.05) | (0.02) | (0.01) | 0.01 | (0.01) | 0.01 | 0.03 | 0.07 |
Graham Number |
27.48 | 26.84 | 30.36 | 40.96 | 38.22 | 52.53 | 62.20 | 71.88 | 93.49 | 103.20 |
Earnings Yield |
3.11% | 2.14% | 2.29% | 2.24% | 1.33% | 2.54% | 2.80% | 3.71% | 3.70% | 5.37% |
Free Cash Flow Yield |
3.11% | 2.93% | 2.16% | 2.51% | 1.73% | 0.64% | 1.74% | 4.68% | 4.36% | 5.74% |
Revenue per Share |
14.62 | 16.39 | 18.21 | 20.49 | 22.00 | 24.50 | 28.77 | 31.87 | 35.08 | 38.85 |
Operating CF per Share |
2.93 | 3.54 | 3.21 | 5.56 | 5.07 | 2.40 | 4.72 | 9.53 | 11.94 | 12.41 |
Capex per Share |
(0.51) | (0.50) | (0.54) | (0.73) | (0.80) | (1.07) | (0.91) | (0.78) | (0.69) | (1.22) |
Free Cash Flow per Share |
2.42 | 3.04 | 2.67 | 4.82 | 4.27 | 1.34 | 3.81 | 8.75 | 11.25 | 11.19 |
Cash per Share |
5.81 | 1.32 | 1.03 | 3.21 | 2.03 | 1.87 | 1.55 | 1.62 | 8.24 | 10.10 |
Shareholders Equity per Share |
13.87 | 14.42 | 14.48 | 17.30 | 19.86 | 23.01 | 28.14 | 33.08 | 40.68 | 45.25 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.87 | 14.42 | 14.48 | 17.30 | 19.86 | 23.01 | 28.14 | 33.08 | 40.68 | 45.25 |
Free Cash Flow |
342.58 | 433.57 | 381.71 | 696.32 | 619.89 | 195.11 | 559.30 | 1,286.40 | 1,650.95 | 1,628.66 |
Working Capital |
1,283.88 | 554.47 | 589.38 | 920.70 | 662.99 | 1,242.18 | 1,609.30 | 1,447.06 | 2,486.49 | 2,929.63 |
Capital Expenditures |
(71.48) | (71.46) | (77.34) | (105.94) | (116.83) | (156.04) | (134.00) | (114.86) | (100.64) | (177.17) |
Net Current Asset Value |
135.78 | 60.77 | (890.12) | (566.89) | (267.69) | 196.38 | (253.97) | 349.37 | 1,299.07 | 1,944.18 |
EV/EBIT |
26.45 | 27.49 | 32.50 | 35.09 | 40.03 | 31.10 | 29.40 | 21.17 | 22.13 | 14.46 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 |
Price to Operating Income |
25.85 | 27.34 | 30.58 | 34.23 | 39.64 | 30.61 | 28.33 | 20.82 | 22.46 | 15.03 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.28 | 0.31 | 0.39 | 0.43 | 0.41 | 0.39 | 0.37 | 0.39 | 0.43 | 0.42 |
Cash ROIC |
8.87% | 17.22% | 10.97% | 16.88% | 16.21% | 4.43% | 9.66% | 22.18% | 21.07% | 19.26% |
Accounts Receivable Turnover |
4.96 | 5.01 | 5.15 | 5.90 | 5.87 | 6.01 | 6.59 | 6.08 | 5.79 | 5.72 |
Accounts Payable Turnover |
9.33 | 10.84 | 10.67 | 9.85 | 9.92 | 10.45 | 12.05 | 10.45 | 8.11 | 7.50 |
Inventory Turnover |
3.51 | 3.74 | 3.60 | 3.23 | 3.11 | 2.59 | 2.14 | 2.23 | 2.39 | 2.35 |
Average Days of Payables |
39.14 | 33.67 | 37.97 | 39.99 | 37.10 | 37.41 | 29.47 | 42.74 | 48.55 | 51.21 |
Days of Inventory on Hand |
113.22 | 97.56 | 114.71 | 122.80 | 122.87 | 174.75 | 195.08 | 147.84 | 161.91 | 156.80 |
Average Receivables |
416.31 | 467.11 | 506.08 | 501.56 | 544.47 | 595.12 | 640.43 | 771.09 | 888.38 | 987.86 |
Average Payables |
92.67 | 92.74 | 104.22 | 125.76 | 136.90 | 148.63 | 155.00 | 194.24 | 257.94 | 293.54 |
Average Inventory |
246.39 | 268.51 | 309.17 | 383.28 | 436.97 | 600.47 | 870.96 | 910.13 | 874.98 | 936.76 |
Average Assets |
3,362.60 | 3,266.21 | 3,585.80 | 4,347.53 | 4,657.75 | 4,911.99 | 5,923.78 | 6,812.05 | 7,523.39 | 8,570.17 |
Average Common Equity |
1,827.55 | 2,009.62 | 2,065.59 | 2,284.61 | 2,691.35 | 3,123.22 | 3,745.33 | 4,496.97 | 5,415.95 | 6,276.63 |
Columns are period end dates